& vaccination as well as capacity expansion. OPD increased by 4 units and IPD increased by 22 units yoy. OPD income was driven by revenue per head while number of patients (not included outside check-up
impact and extra item, the Company had the normalized total revenue and share of profit and normalized net profit of THB 1,399.5 mm and THB 196.5 mm, respectively. The details are as follows: FINANCIAL
Bt2,008.5 million, a decrease of Bt116.1 million or 5.5%(y-o-y) and EBITDA margin was at 55.2% which was lower than 57.2% of 2016. However, excluding extra income from 2016, the EBIT margin for the year 2017
%, primary by higher Gross Profit of High-Valued Document. Excluding extra expenses that are combined as part of the cost of sales in 2Q19. Consisting of the impact of the legal adjustment of compensation for
. This was primarily due to the Company’s business expansion which incur higher expense as well as extra expanses for new subsidiaries that operating commercial real estate business and food and beverage
million which decreased by Bt71.7 million or 60.8%(y-o-y) as a result of in the nine months of 2016 the other income was recorded for the extra revenue of Bt72.2 million which were the compensation
incurred from deferred tax. This extra transaction was included in year ended 2017 financial statement for the net amount of THB 24 million. Revenue from Hospital Operations Revenue from hospital operations
impact and extra item, the Company had the normalized total revenue and share of profit and normalized net profit of THB 1,885.0 mm and THB 518.1 mm, respectively. The details are as follows: FINANCIAL
reported at 21.6%, nearly to %GP 9M18 represented at 21.7%. Excluding TBSP %GP at 17.2%, Company’s core %GP achieved at 24.9%, primary by higher Gross Profit of High-Valued Document. Excluding extra expenses
Position and THB million Q1’19 Q1’18 %Chg As Reported (% to Sales) Total Admin Exp. 69(10.5%) 42(13.4%) 65.0% TKS 41(6.2%) 39(12.6%) 4.7% One-off Extra exp. - 3(0.8%) (100.0%) Company 41(6.2%) 42(13.4%) (1.9